2151-4658/asset/olbannerleft.gif?v=1&s=75d1dd4933b4687fdb365bb32190b0a4ef453ee7)
2151-4658/asset/olbannerright.gif?v=1&s=a36ba6af41bd9af370864f6461a516746a709d31)
Original Article
You have full text access to this OnlineOpen article
Role of initial NSAID choice and patient risk factors in the prevention of NSAID gastropathy: A decision analysis
Article first published online: 7 FEB 2002
DOI: 10.1002/art1.10159
Copyright © 2002 by the American College of Rheumatology
1529-0131a/asset/cover.gif?v=1&s=4b71f39689e424fbb0e6725b1c033cc646a4272b "Arthritis Care & Research")
Additional Information
How to Cite
Fendrick, A. M., Bandekar, R. R., Chernew, M. E. and Scheiman, J. M. (2002), Role of initial NSAID choice and patient risk factors in the prevention of NSAID gastropathy: A decision analysis. Arthritis & Rheumatism, 47: 36–43. doi: 10.1002/art1.10159
Publication History
- Issue published online: 7 FEB 2002
- Article first published online: 7 FEB 2002
- Manuscript Accepted: 1 JUL 2001
- Manuscript Received: 5 APR 2001
Funded by
- SmithKline Beecham
- Abstract
- Article
- References
- Cited By
Cited in:
- CrossRef
This article has been cited by:
- 1, , , Reduced Hospitalization Cost for Upper Gastrointestinal Events That Occur Among Elderly Veterans Who Are Gastroprotected, Clinical Gastroenterology and Hepatology, 2010, 8, 4, 350
- 2, Balancing Risks and Benefits of Cyclooxygenase-2 Selective Nonsteroidal Anti-Inflammatory Drugs, Gastroenterology Clinics of North America, 2009, 38, 2, 305
- 3, , , Impact of patient sample on costs of events in pharmacoeconomic models, Expert Review of Pharmacoeconomics & Outcomes Research, 2008, 8, 5, 463
- 4
- 5, , , , , , Minimizing risks of NSAIDs: cardiovascular, gastrointestinal and renal, Expert Review of Neurotherapeutics, 2006, 6, 11, 1643
- 6, , , , , , Primary care physician perceptions of non-steroidal anti-inflammatory drug and aspirin-associated toxicity: results of a national survey, Alimentary Pharmacology & Therapeutics, 2006, 23, 5Direct Link:
- 7, , Gastrointestinal adverse effects of non-steroidal anti-inflammatory drugs, Expert Opinion on Drug Safety, 2005, 4, 2, 157
- 8, , , Minimizing complications from nonsteroidal antiinflammatory drugs: Cost-effectiveness of competing strategies in varying risk groups, Arthritis Care & Research, 2005, 53, 2Direct Link:
- 9, , Informed Choices in Anti-Inflammatory Drug Therapy, JCR: Journal of Clinical Rheumatology, 2004, 10, 4, 157
- 10, , , , Treatment Costs to Prevent or Treat Upper Gastrointestinal Adverse Events Associated with NSAIDs, Drug Safety, 2004, 27, 13, 1019
- 11, , , , , Utilization of nonsteroidal anti-inflammatory drugs and antisecretory agents: a managed care claims analysis, The American Journal of Medicine, 2004, 116, 12, 835
- 12, , An evidence-based approach to studies of gastrointestinal therapies, Clinical Gastroenterology and Hepatology, 2003, 1, 1, 57
- 13, Cyclooxygenase-2 inhibitors and nonsteroidal anti-inflammatory drugs in the management of arthritis, Foot and Ankle Clinics of North America, 2003, 8, 2, 187
- 14Current Awareness: Pharmacoepidemiology and Drug Safety, Pharmacoepidemiology and Drug Safety, 2002, 11, 6Direct Link:
- 15, , , Nonsteroidal antiinflammatory drugs and the stomach, Current Opinion in Gastroenterology, 2002, 18, 6, 658